Asthma is Different in Women

Abstract

Gender differences in asthma incidence, prevalence and severity have been reported worldwide. After puberty, asthma becomes more prevalent and severe in women, and is highest in women with early menarche or with multiple gestations, suggesting a role for sex hormones in asthma genesis. However, the impact of sex hormones on the pathophysiology of asthma is confounded by and difficult to differentiate from age, obesity, atopy, and other gender associated environmental exposures. There are also gender discrepancies in the perception of asthma symptoms. Understanding gender differences in asthma is important to provide effective education and personalized management plans for asthmatics across the lifecourse.

Introduction

Nearly 40 million people (12.9 %) in the Unites States are diagnosed with asthma [1]. This chronic inflammatory airway disease results in~$50 billion per year cost to society in addition to the significant loss of productivity of individuals who suffer from asthma [1–4]. There is convincing evidence to support gender effects in the pathophysiology and severity of asthma [Table 1].

Table 1.

Studies on Gender differences in Asthma

First author (Reference)	Type of Study	Country of Origin	Number of subjects	Age range (yrs)	Findings
Patel [5]	Multi-center randomized control trial	New Zealand	303	16–65	Female gender was associated with future exacerbations [RR 2.3 (95 % CI, 1.3–3.7)]
Vink [13]	Prospective cohort study	The Netherland	2,230	10–18	A shift in the prevalence of asthma occurs between 11.1 and 16.3 years.
Fuchs [15]	Cross-sectional population-based surveys	Austria, Germany, Switzerland	34,491	6–12	Children living on farms are protected against wheeze independently of atopy.
Balmes [19]	Cross-sectional observational study	USA	302	18–50	Ambient particulate matter and nicotine were associated with more symptoms in women only [OR 2.4(95 % CI:1.3–4.5)]
Willeboordse [22]	Online questionnaire	The Netherland	39,316	6–16	Asthma and BMI were only related in girls [aOR: 1.31 (95%CI: 1.13–1.51)]
Quek [25•]	Cross-sectional observational study	Taiwan	114	5–18	Serum leptin levels were significantly higher for overweight girls with asthma
Tantisira [30]	Observational phase of a prospective, randomized trial	USA	1,041	5–18	Airway responsiveness persists in females after the age of 11 years compared to males.
Dong [34]	Questionnaire based survey	China	30,139	3–12	The effect of air pollution on asthma was stronger in non-topic boys and in atopic girls.
Wijga [37]	Longitudinal study of birth cohort	The Netherland	3,308	0–8	The prevalence of asthmatic wheeze was higher in boys than girls
Leynaert [39]	Population-based cohort	29 centers from 14 European countries	9,091	20–44	Women had higher incidence of non-allergic asthma during the reproductive years [HR 3.5 (95 % CI: 2.2 – 5.6)]
Arshad [44]	Longitudinal study of a birth cohort	UK	1,456	0–18	Male Sex was associated with remission during adolescence [OR: 0.3 (95 % CI: 0.1–0.7)]
Haselkorn [56]	Prospective study	USA	1,261	6–17	IgE levels were higher in boys
Malling [57]	Cross-sectional study	Denmark	1,191	20–44	Women had higher activities of most antioxidant enzymes.
Moore [28]	Cross-sectional study	USA UK	726	6–72	Cluster of older women with late-onset nonatopic asthma, reduced FEV1 and frequent exacerbations
Puberty and Asthma
Rao [61•]	Cross-sectional study	USA and UK	92	12–50	PMA is common in women with severe asthma, and is associated with Aspirin sensitivity suggesting alterations in prostaglandins.
Al-Sahab [63]	Prospective population-based cohort	Canada	1,176	8–11	Early menarche was associated with twice the risk of having asthma during early adulthood [OR: 2.3 (95 % CI: 1.2, 4.6)].
Salam [64]	Population based cohort	USA	905	13–28	Wheezing was lower in women using Oral Contraceptives [OR: 0.18 (95 % CI: 0.06–0.56)]. Women with early menarche had a 2.1-fold higher risk of asthma.
Jenkins [66]	Questionnaire survey from a population-based cohort	Australia	681	29–32	Asthma in women was predicted by parity and lower oral contraceptive use
Osei-Kumah [72••]	Case control study	Australia	49	23–31	Only 6 genes were altered in male placentae compared to 59 genes changes in female placentae.
Farha [74••]	Prospective observational study	USA	23	27–35	Airflow and lung diffusing capacity varied over the menstrual cycle in asthmatic women.
Menopause and Asthma
Troisi [76]	Prospective cohort study	USA	36,094	34–68	The risk of asthma was lower in menopausal women [RR: 0.65 (95CI: 0.46 – 0.92)], and increased with the use of PHT
Real [79]	Cross-sectional study	Norway, Spain, France Sweden, UK Switzerland, Germany	1,274	45–56	Menopausal women, especially those with BMIs of less than 23 kg/m2, had lower lung function and more respiratory symptoms
Jarvis [82]	Annual cross-sectional survey	UK	3,724	35–64	Current use of PHT, particularly in lean women, was associated with wheezing[OR: 1.9 (95CI: 1.2–3.1)]
Romieu [83•]	Prospective cohort study	France	569	40–65	Menopausal women, particularly never smokers, using estrogen alone had higher risk of asthma [HR:1.54 (95 % CI: 1.13 to 2.09)]

OR odds ratio, aOR adjusted odds ratio, RR relative risk, CI confidence interval, BMI body mass index, PHT postmenopausal hormone therapy, UK United Kingdom, PMA premenstrual asthma, USA United States of America

Epidemiological data show that asthma incidence, prevalence and severity differs according to gender. Asthma prevalence, severity, exacerbation rate, hospitalizations and mortality are higher among women than men overall; however, asthma related office and emergency room visits and hospitalizations are higher among boys than girls 0 to 14 years of age [3, 5–10]. The reasons for the gender difference are unknown but have been linked to immunological and hormonal factors, and/or to differences in gender-specific responses to environmental or occupational exposures [11–14]. For example, children living on farms have a lower incidence of asthma [15], which has been related to modulation of the immune system by early life exposures, differences in physical activity levels or eating habits [16, 17]. However gender influences the impact of this exposure, i.e. the cumulative asthma incidence is lower in girls as compared to boys raised on a farm [18]. Asthma in early childhood is generally associated with male gender, poor socioeconomic status, and exposure to soot, exhaust and/or household tobacco, wood, or oil smoke [19, 20]. Yet, asthma in early childhood is only associated with obesity in young girls, not in young boys in two large cross-sectional series from China and the Netherlands [21, 22], and in two longitudinal cohorts from the United Kingdom and Taiwan. The U.K. study followed children longitudinally until the age of 8 years and found that a higher body mass index (BMI) was associated with increased wheezing in girls but not in boys [OR (95CI): 1.52 (1.01, 2.28)] [23]. The Taiwanese study followed adolescents prospectively for 12 months, and reported that obese adolescent females but not males were at higher risk of developing asthma [24]. Interestingly, higher serum leptin levels were associated with obesity, female gender and asthma [25•]. Leptin, which plays a key role in body weight regulation, promotes Th1 immune responses and increases the production of pro-inflammatory mediators [25•]. The gender dimorphism of the obese-asthma phenotype is supported by the finding that asthma impairment related to obesity is highest among women 12 to 44 years of age [26, 27]. The European Network For Understanding Mechanisms of Severe Asthma (ENFUMOSA) and Severe Asthma Research Program (SARP) identified that there was a higher ratio of female to male gender (4.4:1) in severe asthma as compared to nonsevere asthma, and that BMI was higher among severe asthmatic women as compared to nonsevere asthmatic women, but was not different among nonsevere and severe asthmatic men [9, 28, 29]. Thus, most reports, but not all [30], suggest a gender-obesity interaction in asthma, but it remains unclear whether the sex hormones or other gender-specific factors are responsible for such differences.

Interestingly, the lifetime diagnosis of asthma and current asthma was recently reported to be higher among same-sex partnered men and women. Such increased risk may be mediated by a higher prevalence of obesity among same-sex partnered women and by the higher prevalence of smoking among same-sex partnered men [31]. A higher prevalence of asthma is also found in women with attention deficit hyperactivity disorder (ADHD) as compared to men with ADHD, which has been related to higher prevalence of smoking and obesity [32] among individuals with ADHD. Thus, it is imperative to assess the role and impact of confounders before confirming or dismissing associations between gender and asthma.

Exposure to particulate matter or to second-hand smoking [33] are associated with lower Forced Expiratory Volume in the first second (FEV1) in women younger than 55 years of age, but not in men. The role of air pollution was recently assessed in 30,139 Chinese children aged 3 to 12 years. Among those children, respiratory symptoms in relation to air pollution were reported more frequently by girls with allergic tendency, whereas effects were more prominent in the non-allergic boys [34]. In this context, there is a higher incidence of non-atopic asthma in women during the reproductive period as compared to men, but no gender difference in the incidence of atopic asthma. [35, 36]. Altogether, there is evidence to suggest an interaction between gender, obesity and asthma type (atopic vs. nonatopic). This indicates an effect modification by age, BMI and gender on the response to risk factors and environmental exposures [19].

Sex hormones and Asthma

Asthma is more prevalent and severe in young boys [37, 38], but there is a gender-switch at puberty, which has been related to increase of sex hormones [9, 39, 40]. The transition from childhood to adulthood is characterized by a higher odds ratio of persistence of wheezing in females [41, 42], and by asthma improvement in males but asthma worsening in females [43]. In two cohorts of patient followed longitudinally until the age of 18 years, male gender was independently associated with asthma remission [13, 44, 45]. After age of 11 years, the provocative concentration of methacholine necessary to cause a 20 % decrement in FEV1 (PC20) increased in adolescent boys suggesting an improvement in airway responsiveness during puberty in boys but not in girls [30]. The male-specific increase in PC20 was seen after Tanner stage 2, and further increased with sexual maturation [30]. In contrast, adult women with stable well-controlled asthma decrease PC20 by more than half over the course of the menstrual cycle, with the lowest PC20 occurring at peak estrogen and progesterone levels in the luteal phase [46]. The cyclic changes in PC20 have been attributed to abnormal β2 adrenoceptor regulation in premenstrual asthma [46, 47]. It has been suggested that β2 adrenoceptors are influenced by ovarian sex-steroid hormones, and that this is the mechanism underlying gender differences in β2 bronchodilator responses [47]. This concept is supported by the paradoxical down regulation of β2 adrenoceptors when progesterone is given during the follicular phase to women with premenstrual asthma [47–49]. On the other hand, estrogen supplementation during the follicular phase had no effect on β2 adrenoceptor responses or airway reactivity [48, 50]. Interestingly, while higher progesterone to estrogen ratio occurs during the luteal phase of fertile cycles [51, 52], the opposite occurs during the menopausal transition, where women are exposed to unopposed estrogen stimulation [53]. Thus, it remains unclear as to whether progesterone and/or estrogen or a balance between the sex hormones are responsible for premenstrual worsening of asthma.

Sex hormones have a wide variety of effects beyond the β2 adrenoceptor. For example, sex hormones alter function of epithelial cells. The progesterone receptor is expressed in airway epithelium and progesterone inhibits the beat frequency of cilia, which may impact mucociliary clearance during menstrual cycle among women [54]. Genetic polymorphisms are also influenced by gender. Immunoglobulin E (IgE) levels and asthma have been associated with single nucleotide polymorphisms (SNPs) in thymic stromal lymphopoietin (TSLP). Two SNPs in TSLP (rs1837253 and rs2289276) are of particular interest. The first is associated with a lower risk of asthma in men, but the second is associated with a higher risk of asthma in women. Whether this differential effect is regulated by gender, or the sex-related differences in the hormonal profile is unknown [55]. Likewise, in a series of 1,261 children and adolescent with moderate to severe asthma, enrolled in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) cohort, IgE levels were higher among boys 6 to 17 years old compared to girls, but girls had higher IgE levels during puberty (12–14 years). A higher IgE level was associated with more symptoms triggered by dust, pollen and animals, and was associated with a lower FEV1/FVC ratio even after adjustment for age, gender and race [56]. Gender-specific differences in the antioxidant response to oxidative stress have been reported. In unadjusted analyses, the activities of superoxide dismutase, glutathione peroxidase, and glutathione reductase were higher among asthmatic women than men [57].

The Role of Puberty

After puberty, a gender switch occurs, and asthma becomes more prevalent and severe in women [30, 40, 58]. Dysanapsis, which refers to the differences in the relative growth of airways and parenchyma, accounts for why boys, who have larger lungs, do not necessarily have larger airways as compared to girls. Later, this differential parenchymal-airway growth is reversed, and may in part be responsible for increased asthma severity in adult women [11, 59, 60]. The exact age at which the gender switch in asthma occurs is based mostly on cross-sectional data and varies among reports from 11 to 18 years of age [1, 4, 13, 40]. Nevertheless, the gender switch is consistent regardless whether information on asthma prevalence, asthma severity or cost to society are used to predict the age of the switch [1] [Fig. 1]. A recent report examined the role of sex hormones on asthma development longitudinally and found that the shift in the prevalence of asthma starts after the age of 11.1 years and remains until the age of 16.3 years. Many reports have linked female sex hormones to asthma severity. Women with premenstrual asthma are at are at higher risk for severe asthma, required more bursts of corticosteroids therapy, and have a higher risk for emergency room visits, hospitalization, and admission to the intensive care unit [61•]. Interestingly, asthmatic women receiving oral contraceptives have attenuated cyclical changes in airway reactivity in association with a suppression of the upsurge in progesterone and estradiol during the luteal phase [62]. Consistent with a detrimental role of sex hormone in women with premenstrual asthma, the risk of asthma increases by as much as two fold in girls who exhibited early menarche [63–65]. In multiparous women, asthma prevalence increases linearly with the number of births [66]. Girls who mature early, and pregnant women are likely to be exposed to higher estrogen levels, and greater cumulative hormonal exposure of sex hormones, which place them at higher risk for asthma development later in life. In contrast, oral contraceptive may be protective [66] and decrease the risk of exacerbation in asthmatic women [64].

Fig. 1.

Adapted from 2012 National Health Interview Survey (NHIS) Data [1]. Lifetime asthma prevalence (percent) stratified by age and gender, United States. The lifetime prevalence in asthma is higher in boys until the age of 14 and in girls after the after of 15 years

In pregnant women, female sex of the fetus is linked to risk of asthma severity. It is interesting to speculate that this may be related to a spillover of fetal sex hormone into the maternal circulation. While many reports have reported that carrying a female fetus is associated with increased asthma symptoms during pregnancy, a higher use of asthma medications and a higher risk of asthma related hospitalization [67–70], a larger Canadian study did not confirm the finding [71]. Recent reports have demonstrated sex-specific alterations in the expression of placental genes of pregnant women with asthma compared to placentae of non-asthmatic mothers. There were a small number of genes with altered expression (6 genes) in placentae of asthmatic women carrying male fetuses, as compared to 59 genes with altered expression in placentae of asthmatic mothers carrying female fetuses. The genes were linked to growth, inflammation and immune pathways and might contribute to the fetal-sex dimorphic differences in asthma severity and fetal growth during pregnancy [72••].

Perhaps some of the strongest evidence in favor of a role of sex hormones in asthma is the worsening asthma symptoms in the premenstrual period, which occurs in one third of women, and the beneficial role of oral contraceptives [61•, 66], which regulate and prevent the harmful effect of estrogen and progesterone fluctuation. The role of sex hormones in asthmatic women is also supported by the findings of abnormal sex hormone levels among asthmatic women compared to non-asthmatic [73] and by the cyclic changes in FEV1 and gas transfer during the menstrual cycle reaching peaks levels at the end of the luteal phase through the start of menstruation [74••].

The role of menopause

Equally important as the association of asthma to parity, early menarche (<12 years) and the use of oral contraceptives [63, 64, 66, 75], is the protective role of menopause and the deleterious effect of postmenopausal hormonal supplementation [76–78]. The independent effect of menopause on asthma severity may be confounded by the effect of age, obesity, asthma duration and age related comorbidities. Menopause is associated with increased respiratory symptoms and lower FEV1 [79], but another report suggests that menopause is protective [76]. The risk of severe asthma continues to increase in men after the age of 45 years, but not in women [80]. The drop in asthma severity between ages 50 to 65 in menopausal women compared to men supports the theory that asthma improves after menopause.

As sex hormones levels decrease with menopause, the age adjusted risk of asthma may drop in postmenopausal compared to premenopausal women [76, 77]. This protective effect of menopause is reversed by postmenopausal hormone replacement therapy [76, 77, 81, 82]. The highest risk of replacement therapy is in those women using conjugated estrogen [76, 83•], who have a low BMI [78, 82], and are non-smokers [83•]. It remains unknown whether low dose progesterone-based postmenopausal hormonal therapy is safer than the estrogen-progesterone preparations, or whether medroxy-progesterone acetate based combinations used mainly in the United States has different effects than other preparations used in Europe [83•]. It seems that estrogen, progesterone and androgens interact in a complex manner resulting in different airway responses and symptoms variation in patients with asthma, which occur over the lifecourse as well as at different stages within the menstrual cycle.

Menopausal women may not behave similarly, and the effect of perimenopause may be different than of menopause per se. Most women enter the menopausal transition after the age of 45 years once they start having menstrual cycles of variable length [84] as a result of altered ovarian function and exhaustion of the follicular pool. The perimenopausal hormonal abnormalities include hyperestrogenism, hypergonadotropism, and decreased luteal phase progesterone excretion [85]. These changes are associated with a myriad of symptoms including hot flashes, night sweats, depression and poor sleep hygiene [86, 87]. Perimenopausal symptoms get worse before they get better [84]. Furthermore, irregular ovulatory cycles during the perimenopausal period can result in luteal out-of-phase (LOOP) events, i.e. atypical estradiol secretion characterized by a second increase in estradiol during the mid- and late luteal phases [88]. Therefore, asthmatic women may experience different hormonal states as they transition through menopause. This transient hyper-estrogenic state [89–91] may explain the initial deterioration in symptoms and pulmonary function in women entering the menopause transition [79]. After menopause, FSH and LH levels are elevated and estrogen eventually drops to levels seen with surgical oophorectomy. Progesterone levels are also extremely low. This drop in female sex hormones may explain the later protective effect of menopause [76].

It is difficult to separate the physiological and hormonal effect of menopause from other associated behavioral, or psychological factors. Whether increased asthma-related symptoms reported during the early perimenopausal transition, is due to the effect of estradiol levels, or to the misconception and misinterpretation of the vasomotor symptoms remains unclear. Cluster analyses have identified a group of older obese women with difficult-to-manage asthma, who have frequent exacerbations [28]. Studies indicate that the obesity effect on asthma severity is modified by gender [92, 93]. Estrogen and leptin, with are both pro-inflammatory and produced by adipocytes, are higher in obese women as compared to non-obese women. Leptin is associated with increased airway hyper-responsiveness in mouse models [94•], but a direct role in human asthma is unclear and confounded by the respiratory effects of obesity itself [81]. Taking all this into consideration, peri-menopausal women may be at higher risk for severe asthma, and adjustment for age and BMI are necessary to identify the independent role menopause may play in older women.

Differences in perception and behavior

Asthma in women is reported to be more severe and associated with higher health care use [9, 95]. Intriguingly, direct costs due to hospitalization and medication are higher in women compared to men, even after adjusting for the same degree of asthma severity [95]. These findings suggest that women may have a different perception, and take distinct actions regarding their symptoms and asthma control.

The perception of asthma symptoms and airflow obstruction is different between men and women and may be age dependent. While asthmatic women have worse asthma related quality of life, a higher perception of dyspnea, a higher asthma-related healthcare utilization, a higher rate of depression, more rescue inhalers use, and more physical limitation compared to asthmatic men, they have better lung function and similar asthma severity [96, 97, 98•, 99, 100, 101•, 102]. A higher rate of anxiety, excessive daytime sleepiness, and insomnia are reported among women with current asthma compared to men [103]. In line with this, physician-diagnosed asthma is equally prevalent among female and male swimmers (19 %), but women report more respiratory symptoms than men during swimming [104•]. Understanding and using strategies that target this gender-specific difference in disease response and symptom profiles may result in improved asthma related quality of life and health of asthmatic women [105].

Similarly, household and environmental and occupational discrepancies have also been reported among working asthmatics. While working women smoke less than men (18.3 % vs. 22.8 %), they have a higher odds ratio of 2.2 of having diagnosis of asthma [106]. Even with the lower cumulative smoking exposure (number of pack years), asthmatic women with smoking report more wheezing compared to men [107]. Adolescent girls with asthma, but not boys, have more physical tobacco dependence than their nonasthmatic counterparts [108•]. The different workplace exposures between men and women should be taken into consideration when considering gender effects on asthma. Women with work-related asthma are more likely to work in healthcare, educational services, retail trade, and education [109]. While all asthmatics overall are more likely to own a furry pet compared to nonasthmatics (49.9 % versus 44.8 %), and to frequently allow them into the bedroom (68.7 %), asthmatic women have a higher chance of owning a pet compared to asthmatic men [110]. These gender-specific considerations are important to educating asthmatics about asthma control and how to avoid triggers.

Adherence to medications continues to be a major issue in asthma management. While women were much more likely to be educated about asthma control and management and more likely to carry a rescue inhaler than men (61 % vs 30 %) [111, 112], personality traits and the misconception for medication need [113, 114] are additional factors associated with medication adherence. Emergency department visits for acute asthma by adults who ran out of their inhaled medication are more common in men as compared to women [102, 115•, 116]. On the other hand, the higher rate of unscheduled office visits in women might suggest a lower threshold for outpatient healthcare contact [8]. Women need more encouragement and education that men regarding the correct use of peak flow meters [117], and adolescent boys are twice more likely to receive spirometry testing during office visits in a series of 40,528 asthmatic Italian children 6 to 17 years of age [118]. Thus, gender differences in asthma may also be related to behaviors of male and female asthmatics, their adherence to treatment guidelines and to medications and the response of their caregivers to male or female patients.

Conclusion

There is sound evidence in favor of gender effects on asthma incidence and severity throughout the life course. While the clinical and epidemiological data support the role of sex hormones on asthma incidence and severity, the data are confounded by many internal and external factors, such as aging, obesity, atopy, and gender differences in behavior and exposures. Further work is needed to establish the gender impact on asthma in utero, in early-life, at puberty, adulthood and the menopause transition. These studies will also generally reveal novel information on the genesis of asthma and provide new insights for pathway based therapies.